Merck’s Keytruda Faces a Patent Cliff. These New Cancer Drugs Could Take Over.
For many cancers now, the standard treatment is chemotherapy plus an immunotherapy such as Merck Keytruda, the best-selling drug in the world. Many think it will pair two innovations: precisely-targeted chemo drugs known as antibody-drug conjugates, or ADCs, and augmented immunotherapies in the form …
Sharemaestro market context Price below Trend Line 52 weeks +14.4%